Stay updated on Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial

Sign up to get notified when there's something new on the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a technical site update rather than an update to the trial information shown.
    Difference
    0.1%
    Check dated 2026-04-23T22:09:34.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This change does not affect the study data or content presented.
    Difference
    0.1%
    Check dated 2026-04-16T18:35:00.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Site version updated from v3.4.3 to v3.5.0. No study content or user-facing information appears to have changed.
    Difference
    0.1%
    Check dated 2026-03-18T20:36:25.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.2 to v3.4.3, indicating an administrative update to the page version.
    Difference
    0.1%
    Check dated 2026-03-11T17:19:37.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the government-funding notice along with the prior revision entry v3.4.1 were removed; these are minor boilerplate updates that do not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T10:20:02.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Added a site-wide funding/status notice indicating government funding issues and ongoing operations; Updated the page revision from v3.4.0 to v3.4.1. These changes are minor and do not affect study data or page content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:14:50.000Z thumbnail image

Stay in the know with updates to Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page.